Treatment for Glaucoma

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Ross Eye Institute, Buffalo, NY
Glaucoma
Eligibility
Any Age
All Sexes
What conditions do you have?
Select

Study Summary

We are testing the accuracy of Reichert's Tono-Vera tonometer by comparing measurements of IOP with this device and measurements with other commonly-used tonometers, including Goldmann Applanation and iCare.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: Baseline only

Baseline only
Intraocular Pressure

Trial Safety

Trial Design

0 Treatment Group

300 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline only
Closest Location: Ross Eye Institute · Buffalo, NY
Photo of new york 1Photo of new york 2Photo of new york 3
N/AFirst Recorded Clinical Trial
1 TrialsResearching Glaucoma
0 CompletedClinical Trials

Who is running the clinical trial?

Reichert, Inc.Industry Sponsor
1 Previous Clinical Trials
61 Total Patients Enrolled
1 Trials studying Glaucoma
61 Patients Enrolled for Glaucoma
State University of New York at BuffaloLead Sponsor
208 Previous Clinical Trials
43,940 Total Patients Enrolled
3 Trials studying Glaucoma
156 Patients Enrolled for Glaucoma

Eligibility Criteria

Age Any Age · All Participants · 2 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are able to provide signed and dated informed consent form

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.